Dr. Reddy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2040 E Mariposa Ave
El Segundo, CA 90245Phone+1 213-266-5600Fax+1 213-477-2344
Education & Training
- Los Angeles County-Harbor-UCLA Medical Center 1Fellowship, Hematology and Medical Oncology, 2000 - 2003
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1996 - 1999
- David Geffen School of Medicine at UCLAClass of 1996
Certifications & Licensure
- CA State Medical License 1998 - 2025
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- N-803 Plus BCG Treatment for BCG-Naïve or -Unresponsive Non-Muscle Invasive Bladder Cancer: A Plain Language Review.Karim Chamie, Sam S Chang, Charles J Rosser, Eugene Kramolowski, Mark L Gonzalgo
Future Oncology. 2024-01-01 - 21 citationsSafety, Tolerability, and Long-Term Clinical Outcomes of an IL-15 analogue (N-803) Admixed with Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Cancer.Charles J. Rosser, Sergei Tikhonenkov, Jeffrey W. Nix, Owen T. M. Chan, Irina Ianculescu
Oncoimmunology. 2021-05-03 - 8 citationsComplete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study.Leylah Drusbosky, Chaitali Nangia, Andrew Nguyen, Christopher Szeto, Yulia Newton
Journal for Immunotherapy of Cancer. 2020-09-01
Press Mentions
- NantHealth and NantOmics Present Four Research Papers Demonstrating Advancements in Cancer Diagnostics with NantHealth’s GPS Cancer® and Liquid GPS™October 29th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: